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ABSTRACT
Solid phase extraction has become a popular tool for analytical method development
as a sample preparation technique. Solid phase sorbents can generally extract analytes
based on polarity or selectively based on highly specific interactions between the analyte
and an immobilized surface molecule. Biomolecular recognition based solid phases
utilize antibodies, nucleic acids, and proteins as a secondary affinity layer on a solid
phase support for selective analyte extractions and have been used for sample
preparation, purification, separations, bioassays, and molecular diagnostics.
Polymer supports for solid phase extraction are desirable for their low cost,
abundance, chemical inertness, and pH stability. This thesis reports the use of capillarychannel polymer (C-CP) fibers as a solid support modified for selective extraction and on
fiber fluorescence detection of nucleic acids and proteins. The polymer fibers are low
cost and their unique shape allows them to be easily adapted into a fluidic fiber based
micro spin column configuration for a small scale, inexpensive, low-tech, and easy to use
device. Platform performance was successful as demonstrated by modifying the polymer
surface with neutravidin via adsorption to tether specific biotinylated analyte recognition
moieties. Fluorescence resulted from either hybridization of a complementary
fluorophore labeled probe to nucleic acids or conjugation of a fluorophore to the analyte
protein.
On fiber fluorescence detection of nucleic acids and proteins was successful with
minimal non-specific binding of proteins and nucleic acids to the polymer surface. Two
sequence specific oligonucleotides were added and probed either separately or
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simultaneously on the fibers; the fluorescence intensity increasing with the amount of
oligonucleotide added, leveling off at 100 pmol. Fluorescence signal never saturated for
small volume additions (10ul) up to 100 pmol of added oligonucleotide. The LOD was
calculated to be 100s of fmol for all experiments. For selective extraction of proteins,
protein recovery was similar for both C-CP fibers and streptavidin conjugated magnetic
microbeads. Adsorbed neutravidin did not irreversibly bind to the C-CP fiber surface and
was partially removed in the presence of .01% Tween-20.
C-CP fibers and spin columns are inexpensive, easy to use, and can be integrated as a
solid phase extraction sample preparation step for small scale bioassays or molecular
diagnostics.
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CHAPTER ONE
INTRODUCTION
The ability to analyze the composition, quantity, and identity of certain molecular
and biomacromolecular compounds has led to advancements in therapeutics[1-3] and
medical diagnostics[4-8]. Direct analysis can be problematic due to interfering sample
matrix particles and molecules that can suppress or enhance the analyte signal. Samples
that contain trace amounts of analyte are also not suitable for direct analysis because
they can be below the detection limit for most analytical instruments. Solid phase
extraction has become a popular tool to analyze compounds from a variety of complex
mixtures and biological matrices such as groundwater[9-12], urine[13,

14]

, and whole

blood[15, 16]. Solid phase extraction works by extracting out the analyte of interest onto a
solid phase sorbent that has favorable interactions with the analyte. It has been widely
used in analytical method development as a sample preparation step, making the analyte
of interest conducive for downstream application. Depending on the downstream
application the analyte can be purified, isolated, or pre-concentrated. For example, water
purification uses solid phases when extracting drugs[17], pesticides[18], and metals[19]
from ground water. Silica particles and ion exchange resins have been used to extract
DNA before downstream PCR analysis because the salt and protein content found in
DNA samples (from cell lysate) can inhibit enzyme amplification[20-22]. Solid phase
extraction has been used as a sample purification and analyte isolation prior to ESI and
MALDI mass spectrometry detection because biological fluids are composed of many
ions that can interfere or complicate mass spectrometry detection. The salts cause ion
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suppression as well as forming adducts that can add more peaks which complicate
analysis[23-26]. Pre-concentration has been used in both the environmental and forensics
fields for trace analysis of pesticides from environmental samples[11] and for DNA from
forensic samples[27, 28].
Solid phases come in a variety of materials and formats depending upon the
application. Conventional solid phase sorbents packed into cartridges, columns, and
disks[29] are more generally selective and extract the analyte of interest based on its
polarity and electrostatic interactions between it and the sorbent. These phases are
classified into different modes such as normal phase, reverse phase, ion exchange, and
mixed mode extraction[30]. Modified silica is the most used for all modes because it is
easily modified to alter the polarity with different polar and non-polar functional groups
such as C-18, C-8, CN, and phenols[30]. However, silica has disadvantages such as low
pH working range and chemical instability from hydrolysis of the bonded chains, and
the effects of the unreacted silanol groups[30, 31]. This led to carbon based solid phases
which had better chemical stability compared to silica. Carbon solid phases such as
carbon black and porous graphitized carbon were shown to have some degree of polarity
and non-polarity which acted as more of a mixed mode and would extract out polar, non
polar, and ionic substances[31]. However carbon phases irreversibly bound polar analytes
which resulted in poor recovery[31]. Porous polymer resins[32] such as polystyrene
divinylbenzene also have better chemical stability compared to silica however they have
to be pretreated with polar solvents before analyte extraction from aqueous solutions
because the polymer was hydrophobic. This led to functionalized polymer solid phases
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linked with hydrophilic functional groups to allow aqueous solutions to make better
contact with the resin[32].
Silica, carbon, and polymer sorbents are only generally selective and can include
other co-extracted interferences. This has lead to method development that includes a
two step solid phase extraction and downstream separation to fully isolate the analyte, or
multiple elution steps to get rid of the other co-extracted interferences[33]. Also coextracted interferences can also decrease binding capacity, which can be detrimental in
trace analysis. For example, DNA and RNA have been extracted on both ion exchange
and silica sorbents[34]. The negatively charged phosphate backbone on nucleic acids can
be exchanged on an anion exchange phase or hydrogen bonding of nucleotide bases on a
silica phase. However, proteins also bind to the sorbent and have to be removed in a first
elution step with ethanol.
Extraction efficiency is due in part to the affinity of the analyte to the solid phase
sorbent. The introduction of selective sorbents can enhance extraction down to just a
single analyte or a similar group of analytes. This has led to the development of selective
solid phases based off of molecular recognition such as molecular imprinted polymers
(MIP) and immunosorbents. MIPs operate on the principle of using template molecules
bound to functional monomers that are polymerized around it to form cavities in the
shape and size of the template molecule that mimic the actual natural binding sites. The
template molecule is then extracted out of the cavity. They are desirable because the
template holes are in the shape and size of the molecules such as small ionic molecules
and even proteins, which give them their selectivity. They have been used for
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environmental analysis of pesticides[35], and drugs[35,

36]

. However MIPs suffer from

disadvantages. One major one is template bleed through, meaning the template still
remains embedded in the polymer after all the washes to extract it out of the cavity[35].
This disadvantage has been circumvented by the use of a similar analogue as the
template so there will not be bleed through. MIP have also been used for protein
extraction[37] but has disadvantages because of the unstable 3D conformations of
proteins brought on by random motion as well as conformational changes which are
dependent upon the ionic strength, solvent, and pH. Immunosorbents are also based on
molecular recognition and use antibodies that have been raised against an antigen for
selective antigen extraction[12]. Immunosorbents have found the most use in biological
separations[38], but have also been adapted for the extraction of small molecules in
environmental[12, 39] and food samples by using specific antibodies directed against those
antigens[12]. Nucleic acids[40] and proteins[41] have also been used as biomolecular
recognition ligands for solid phase extraction and have found application in areas such
as molecular diagnostics and bioassays[7].
Solid phases also come in a variety of configurations depending on the need,
instrumentation, available resources, and technical skill level required. One such
configuration is the microbead. Biological separations and extractions were
revolutionized after the invention of the microbead in 1976 and become more popular
when they were made magnetizable[42], which made it easier for sample handling and
did away with instrumentation unlike agarose and dextran modified beads which had to
be pelleted by centrifugation. The magnetic microbeads have been made with diameters
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from tens of nanometers to hundreds of micrometers and have been used in bioassays as
solid phase substrates[43-46]. The microbead configuration allowed for smaller scale solid
phase extraction and affinity purification with the potential for parallel and high
throughput applications compared to the traditional solid phase extraction configurations
such as columns, cartridges, and disks which required larger volumes that increased
sample processing time resulting in less throughput. The beads are scalable and can use
smaller volumes of hundreds of microliters because the beads in conjunction with
smaller volumes increase the available surface area available per volume for binding.
Beads are sold either pre-coupled or modified “in house” with specific ligands such as
protein A and G[47,

48]

as well as other antibodies[48] which have been used in

immunoassays and purifications[49, 50], along with streptavidin[43], glutathione[47, 49, 51, 52],
nickel[51, 52], and even conventional solid phase functional groups for other small scale
purifications or bioassays[53]. There is also polystyrene beads which allows for “in
house” customization[54, 55].
Microtitier plates made from various polymers (polystyrene, acrylic, PMMA) are
another configuration that have been used as solid supports for selective extraction. One
example is functionalizing the microtiter wells with either antigen or antibody to test for
the presence of certain antibodies and antigens in serum. When the body is infected with
a particular antigen, such as a virus or a particular allergen, it builds up immunity
towards it by producing antibodies. To test for the presence of these antibodies, the
antibodies need to be extracted out of the serum. The antibodies are extracted onto the
immobilized antigen on the well surface and then probed with a secondary labeled
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antibody for detection. For example, enzyme linked immunosorbent assay (ELISA) is a
pre-screening test where diluted blood serum is applied to an immunosorbent or antigen
modified well in a microtiter plate[56]. The immobilized antibody from the serum sample
is then probed with a secondary antibody linked to an enzyme, and upon addition of a
specific enzyme substrate, the solution in the well will change color if the particular
serum antibody was present. The microtiter plate configuration allows for semiquantitative readout from the well, simple sample application, surface modification, and
the ability to run parallel assays. Plus, the increased sensitivity of enzyme/substrate
detection makes it suitable to detect very small amounts of antibody.
Microfluidics has also found multidisciplinary use in fields of chemical synthesis[57],
fluid delivery[58], and solid phase extraction[59]. Each field has different motivations for
microfluidics. However, all fields find potential for automization, integration, and
portability in these miniaturized, self-contained devices. This has led to a whole area of
research dedicated to the miniaturization of conventional bench top procedures onto a
single chip for a total analysis system[60] known as “lab-on-a-chip.” There has been an
ongoing effort to develop simpler designs in order to make more easily used diagnostic
devices to become more widespread making there way from centralized laboratories to
point of care facilities such as clinical facilities and hospitals. Ultimately, the ideal goal
is to have a “plug and play” device that can be used for as a total analysis system. Part of
that total analysis is to incorporate solid phase extraction into the chip. There has been
research done that has incorporated silica beads, sol-gels, and polymer monoliths into
microchannels for the extraction of nucleic acids[6,
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34, 61-71]

. This has allowed for less

sample handling which reduces contamination, and has expedited analysis time due to
minimal sample volumes needed as well as low elution volumes for nucleic acid
enrichment. There has also been research done where amplification is incorporated on
the chip using various temperature cycling strategies such as miniature heaters, chemical
reactions, as well as just using isothermal amplification[70,

72-75]

. Integrating extraction

and amplification on-chip reduces the risk of sample contamination and degradation of
the nucleic acids.
There has been an ongoing effort to also develop fluidic type devices using low cost,
abundant materials that require very little technical skill and instrumentation. In a low
resource setting or on-site testing there will most likely not be a skilled technician or
instruments needed to handle sample processing and analysis so a practical alternative
would be a rapid, integrated, and portable design with direct extraction from biological
fluids and visual detection (i.e. colorimetric detection) preferably, on a cheap solid
support. There has been research using paper or nitrocellulose membranes for
microfluidic chips and lateral flow assays for this purpose coupled with probes for
colorimetric detection[76-83].
There has already been some research using electrospun fibers as well as polyester,
cotton, silk, and cellulose thread as material for solid phase extraction and fluid
transport[84-103] as an ongoing effort to design simple, cheap, low-tech fluidic devices.
The fiber platform used in the following studies is made possible by production of
capillary channel polymer (C-CP) fibers that are made from textile materials extruded
from a variety of low cost polymers that include polypropylene (PP), polyester, and
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nylon. The shape and geometry of the individual fibers is unique and determined by their
extrusion; we have been working with PP fibers extruded with a series of eight open
channels. Although PP is highly hydrophobic which does not easily wick fluid, however,
when packed together the interdigitation of shaped fibers creates micron-sized channels
with efficient fluid transport and high surface area that still promote fluid wicking for
aqueous solvents when the fluid is passed through by some force, which for us is
centrifugation. As stated before, the type of sorbent used for solid phase extraction
depends on the resources available and the chemistry needed. The PP fiber surface is
hydrophobic so its surface chemistry is not easily altered by pH and has minimal binding
via electrostatic interactions to other predominantly charged species in biological sample
matrices as well as minimal interactactions with the extremely negatively charged
backbone and hydrogen bonding of nucleic acids. Another advantage of the PP
hydrophobic material has shown to be easily modified via protein adsorption[104] which
works well to use them as a simple fluidic platform. C-CP fibers have already
demonstrated platform performance being used in other applications for protein[104, 105]
and metal extraction[106], and purifying proteins by extracting them from high salt
solutions for MALDI anaylsis[107] and have extracted analytes from complex matrices
such as urine and saliva[104] and lysate[108] Similar shaped fibers have been used as
packing materials for column chromatography, where their fluid transfer properties
ameliorate high back pressures otherwise required for large-scale preparative column
chromatography[109-112] Previous work done using PP C-CP have minimized non-specific
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adsorption and have successfully and selectively extracted proteins from buffer and
lysate if the proteins are in the presence of Tween-20[108].
The fiber surfaces can be easily modified via protein adsorption for specific
functionality and can be used as a highly selective solid support for a range of affinity
capture assays and selective solid phase extractions. The fibers in the following chapters
were modified with neutravidin via adsorption for specific recognition of biotinylated
molecules. The avidin-biotin interaction is the strongest non-covalent binding interaction
in nature with a Kd on the order of 10-15 M. Neutravidin, is the deglycosylated form of
avidin, and deglycosylation helps minimize non specific binding unlike avidin and raises
the isoelectric point to a more neutral value (6.3) to give it good solubility in aqueous
solutions. Biotin labeled molecules are good for protein labeling because biotin is small
enough not to disrupt the conformation or alter the proteins activity. Most proteins and
nucleic acids contain or can be easily modified with primary amines or carboxylic acid
groups that can be easily labeled with biotin. This highly stable interaction between
biotin and avidin and its similar analogues has been exploited and used in various assays
where the solid phase is modified with an avidin-like protein in order to bind biotin
labeled molecules. Using this, the following studies in this thesis reports a proof of
principle demonstration of a fluidic fiber platform for selective extraction of
biomolecules by modifying the fibers with NAv via protein adsorption followed by the
addition of a specific biotinylated analyte recognition moiety.
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In the following chapters, individual microscopic PP C-CP fibers are bundled and
pulled into a spectroscopically clear (visible spectrum) 0.8 mm capillary FEP tubing that
was then cut into 0.5 cm pieces and loaded into the narrow end of a 200 ul micro-pipet
tip. When fiber surfaces are modified with molecular recognition elements, each fiberfilled tip becomes a platform for molecular recognition solid phase extraction or assays.
The pipet tip acts as a reservoir for analyte addition. Results reported here describe
application of neutravidin modified PP C-CP fibers to extract and detect nucleic acids
and proteins. Chapter 2 goes over making a selective solid phase modified with
biotinylated [dT]20 for mRNA extraction that is also coupled with on-fiber fluorescence
detection where the mRNA is probed with complimentary fluorescent oligos. Chapter 3
discusses the application of PP C-CP fibers for pull-down assays and comparing protein
recovery between fibers and streptavidin conjugated magnetic microspheres as well as
on-fiber fluorescence detection of the protein of interest. This new fiber configuration is
distinguished by its simple low-tech design, speed, flexibility, and low cost.
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CHAPTER TWO
AN INTEGRATED FLUIDIC PLATFORM FOR EXTRACTION AND DETECTION
OF SIMULATED mRNA ON CAPILLARY-CHANNELED POLYMER FIBERS
With the completion of whole genome sequencing, nucleic acids have found use as
biomarkers in a variety of applications such as molecular diagnostics[113-124] forensics[125127]

gene expression profiling[128-131] detection of biowarfare agents[132] and environmental

analysis[133]. Depending on the application, nucleic acids have been generally extracted
onto silica and anion exchange solid phases by hydrogen bonding and electrostatic
interactions or by biomolecular recognition via complimentary base pairing of a target
nucleic acid strand to an immobilized nucleic acid modified solid support. The
widespread utility of nucleic acid detection is in part due to the development of
inexpensive, simple, rapid, low-tech, microfluidic devices for easier sample preparation
by solid phase extraction of nucleic acids. Molecular biology has revolutionized the field
of bacterial diagnostics as a rapid alternative over bacterial culture using the pathogens
own DNA and RNA as biomarkers to identify and make definitive diagnosis of bacterial
species and its resistance in only a few hours.
A rapid, low-tech and low cost polymer solid support was modified for selective
extraction and highly sensitive detection of simulated mRNA using a novel fiber-based
microfluidic platform made from low cost textile fibers. The simulated mRNA was
designed with oligonucleotide sequences coding for a region of either TNF-α or β-actin
specific mRNA sequences including a [dA]20 tail as a stand-in for the complete mRNA.
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Extraction and detection was integrated on the fibers with downstream analysis that
consisted of on fiber fluorescence detection of the simulated mRNA. Integration of
extraction and detection is desirable because it minimizes sample handling, which can
lead to sample contamination and degradation. Although visual detection is practical for
those areas, it is not as sensitive as alternative detection strategies. A laboratory in a
hospital or clinicians office has moderately skilled staff that could still achieve rapid
processing using simple low-cost designs, but also be able have access to instrumentation
for better sensitivity using fluorescence, electrochemical, or chemiluminescence
detection[43, 134-145].
Experimental Section
Materials
Neutravidin (NAv) was purchased from Thermo Scientific and diluted to 60 ppm into
phosphate buffer saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4, pH 7.4) for all experiments. For a blocking reagent, previous research shows
adding Tween-20 (Rockland) to PBS (PBS-T) at a final concentration of .01% (v/v)
sufficiently reduced non-specific binding[108] All DNA oligonucleotides were purchased
from IDT (IA) and diluted into PBS-T. Biotinylated [dT]20 was diluted to 1 uM in PBS-T
for all experiments.
The PP fibers (Eastman Chemical) were constructed into “tips” by using protocols
referenced elsewhere but with slight modifications[104]. Briefly, 470 PP fibers were
manually wound using a rotary counter and rinsed with 95˚C water, MeOH, ACN, and
milliQ water. Once the fibers dried, the fibers were pulled into 30 cm long, 0.8 mm
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optically clear (visible spectrum) fluorinated ethylene propylene (FEP) capillary tubing
(Cole-Parmer). Tips were created by cutting the bundle down to individual 0.5 cm pieces
leaving a 6 mm gap to fit it to the end of a 200 ul micropipette tip that was then cut and
fitted to the end of a 1 ml micropipette tip that acted as the reservoir for fluids to be
passed through the fiber spin columns during centrifugation. A 15 ml tube collected the
effluent. The apparatus was completed by fitting the tip and reservoir micropipette tip
assembly through a hole that was formed by drilling into the top of the 15 ml tube lid.
Experimental outline
Each functionalization step (including washes in between each reagent addition) for
all experiments used 100 ul of volume (except for small volume experiments which used
10 ul) and spun at 220 X g for 1 min at 21˚C. PP C-CP fiber tips were modified by serial
addition of NAv, biotinylated [dT]20, and either a fluorescent and non-fluorescent [dA]20.
All other experiments for on fiber detection of simulated mRNA were done by similar
modification with NAv, and biotinylated [dT]20, but with serial addition of simulated
mRNA and complementary fluorescent labeled probes (500 nM). All reagents used were
kept on ice until needed.
Data acquisition and analysis
With the fibers still packed into the tubing, the fluorescence from the fiber tips was
detected and imaged at 2X magnification (2X/.08 NA UPlan) using an eppifluorescence
microscope (Olympus IX71) connected to an Orca-ER (Hamamatsu) CCD camera and
Xe arc lamp excitation source. The fluorescence for fluorescein amidite (FAM) and
Texas Red labeled oligos was detected using 494 ex/ 531 em filter and 575 ex/624 em
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filter respectively. The fluorescent
A

fiber images were collected and

B

quantified using Slidebook 5.0.

1	
  mm

Each experiment used 3 fiber tips

B

and the average fluorescence
intensity from each single fiber tip
was averaged over the triplicate
tips. All plots were generated using
Kaleidaraph 4.1 (Synergy
Software).
Figure 2.1. Fiber tips are a platform for
mRNA extraction. 0.5 cm fiber tips in
triplicate. A Representative images. The top
left panel shows a fiber that was treated with
NAv followed sequentially by biotin [dT]20,
and a FAM labeled [dA]20. The center and
right most panel show no fluorescence. Both
tips were treated with Nav, but the center one
was treated with a FAM lableled [dA]20 but
had no biotin[dT]20, and the right had
biotin[dT]20 but a non- fluorescent [dA]20 B
Barplot of the average fluorescence intensity
from the fiber tips with standard deviation
bars. The inset shows the fluorescence from
the two controls.

Results and discussion
Solid phase extraction can be
made more selective by modifying
the solid support with specific
analyte recognition moeities. A
model system was first constructed
to generally extract mRNA on the
fibers.

Most

mRNA

found

in

mamillian cells are tagged with a

polyA tail. This made it easy to design and test a model system that used a biotinylated
[dT]20 tethered onto the C-CP fibers via NAv to extract the mRNA by [dA]20/[dT]20
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hybridization. A FAM labeled [dA]20 was then added as a fluorescence indicator for
[dA]20/[dT]20 hybridization.
As shown in Figure 2.1 successful
FAM

hybridization

TxRd

was

achieved

with

significant fluorescence associated with
fiber tips treated with NAv, biotinylated
Coding sequence

oligo, but not with tips in the absence of
biotinylated [dT]20. The data also shows
AAAAAAAAAAAAAAAAAAAA

Bio
NAv

TTTTTTTTTTTTTTTTTTTT

AAAAAAAAAAAAAAAAAAAA

Bio
NAv

[dT]20 and the [dA]20 fluorescent labeled

TTTTTTTTTTTTTTTTTTTT

AAAAAAAAAAAAAAAAAAAA

TTTTTTTTTTTTTTTTTTTT

Complementary fluorescent probe

TxRd

very minimal non-specific binding of the
FAM labeled [dA]20 compared to a
control where a non-fluorescent [dA]20
was used which suggest that DNA

Bio

oligos (in the presence of PBST) do not

NAv

adsorb to the PP fiber surface also

C-‐CP	
  Fiber
Figure 2.2. Illustration depicting the
hybridization model used for on-fiber
extraction and detection of synthetic
mRNA. The PP fiber was modified with
NAv via adsorption followed by the serial
addition of biotinylated [dT]20, simulated
mRNA, and complimentary fluorescent
labeled probe.
extraction.
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suggesting the presence of adsorbed
NAv on fiber surface, and demonstrates
that adsorbed NAv can be used to tether
biotin-linked recognition elements to the
fibers

as

a

platform

for

mRNA

mRNA extraction and detection
A

was then integrated on the fibers by
probing the simulated mRNA with a
complementary

fluorescent

labeled

probe. Integration of extraction and
detection is desirable because it
minimizes sample handling, which can
B

lead to sample contamination and
degradation
important

which
when

is

especially

handling

nucleic

acids. The model was constructed as a
nucleic acid hybridization sandwich
configuration
Figure 2.3. Successful integrated on-fiber
extraction and detection of synthetic
mRNA. Representative images and barplots
(with standard deviation bars, n=3) of the
fiber tips at different amounts of added A
TNF-α and B β-actin simulated mRNA.
LOD was calculated to be 260 and 140 fmol
for TNF-α and β-actin respectively.

(Figure

2.2)

with

biotinylated [dT]20 tethered to the
NAv modified fiber surface followed
by the addition of simulated mRNA
tagged with a polyA tail, then probing
with a complementary fluorophore

labeled oligonucleotide. The simulated mRNA was designed with oligonucleotide
sequences coding for a region of either TNF-α or β-actin specific mRNA sequences
including a [dA]20 tail as a stand-in for the complete mRNA.

16

By
A

using

described

the

above,

model

system

simulated

TNF-

α (Figure 2.3A) and β-actin mRNA
extraction and fluorescence detection
was successfully integrated (Figure
2.3B) directly on the fibers. Fiber tips
were modified by serially spinning
B

through NAv and biotinylated [dT]20
followed by treatment with different
amounts of either simulated TNF-α or
β-actin; bound simulated TNF-α and
β-actin

were

then

detected

via

complementary FAM and Texas Red
Figure 2.4. Two-plex detection of synthetic
mRNA with fmol LOD. Representative
images and barplots (with standard deviation
bars, n=3) of the fiber tips at different
amounts of added A TNF-α and B β-actin
simulated mRNA. LOD was calculated to be
90 and 140 fmol for TNF-α and β-actin
respectively.

labeled probes. The two probes were
linked

to

spectrally

separate

fluorescent dyes (FAM and Texas
Red) to allow independent detection of
both TNF-α and β-actin, and detected

via their respective dye’s different emission. The LOD for on-fiber detection of TNF-α
and β-actin was calculated to be 260 and 140 fmol respectively. Figure 2.3 also shows
very low fluorescence associated with tips not exposed to the simulated mRNA oligos.
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Instead, those tips were treated with 1
A

uM of randomly generated oligo. An
ideal assay would allow detection of
multiple analytes in a single assay.
The advantage of using fluorescence
detection is the capability to be able to
detect multiple mRNAs on a single
fiber tip to maximize throughput of

B

measuring multiple gene sequences
simultaneously.

Using

model

fluorescence

system,

the

same
was

detected for both simulated β-actin
and TNF-α on the same tip. Both βFigure 2.5. On-fiber detection of small
volumes. Representative images and barplots
(with standard deviation bars, n=3) of the
fiber tips at different amounts of added A
TNF-α and B β-actin simulated mRNA.
LOD was calculated to be 400 fmol for both
TNF-α and β-actin.

actin and TNF-α were diluted together
where β-actin was concentrated 10
fold more than TNF-α. The fibers
were

modified

with

NAv

and

biotinylated [dT]20 followed by the

addition of the TNF-α/β-actin mixture and lastly a mixture of the complimentary
fluorescent labeled probes. Figure 2.4 demonstrates that fiber tips can be multiplexed
still yielding low LOD of 140 and 90 fmol for β-actin and TNF-α respectively. As many
as ten genes could be detected in one tip if individual detection probes were labeled with
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different quantum dots with individual emission wavelengths[146] Another advantage of
microfluidics is the ability to use small volumes. The fibers, when packed together into
the capillary tube make narrow channels a few tens of micrometers wide. Figure 2.5
shows that we can still extract and probe the simulated mRNA using 10 ul volumes with
400 fmol LOD for both TNF-α and β-actin.
Conclusion
An inexpensive, simple, low-tech fluidic fiber solid phase was successfully
demonstrated for integrated extraction and detection of nucleic acids using PP C-CP
fibers with 100s of fmol LOD using fluorescence detection. The speed is notable where it
only takes 1 min per centrifuge spin for each molecular addition. Hence, the entire
process (NAv adsorption, tethering of [dT]20, mRNA capture, and detection probe
hybridization) can take as little as six minutes outside of pipetting and image collection.
The PP also has minimal non-specific binding of the DNA oligos in the presence of
PBST. The method requires only an imaging apparatus and centrifuge, and is therefore
likely to be of use in point of care or near point of care applications. For future directions
to reduce costs and data acquisition time, we envision adaptation to visual on-fiber
detection by substitution of fluorescent dyes used here for visible dyes (blue dextran) or
gold nanoparticles[80] This data, together with other publications using C-CP fibers,
suggest that the fibers can be used as a platform for a variety of other selective extraction
of proteins and metals from complex biological fluids and matrices.
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CHAPTER THREE
COMPARING MODIFIED CAPILLARY-CHANNELED POLYMER FIBERS FOR
SELECTIVE PROTEIN EXTRACTIONS AND RECOVERY WITH STREPTAVIDIN
CONJUGATED MAGNETIC BEADS
Protien-protein interactions inside a cell act as cues that mediate cellular function and
gene expression[147-150]. The most common tools used for confirming and discovering
specific protein-protein interactions inside cells are yeast two hybrid (Y2H)
phage

display[152,

153]

,

tandem

affinity

purification[151],

and

[150, 151]

pull-down

,

or

immunoprecipitation assays.
A pull-down assay is another in-vitro affinity purification method used to help
confirm or discover stable protein-protein interactions from a cell lysate. Proteins are
purified and/or isolated out of solution (usually cell lysate) by affinity to antibodies (for
immunoprecipitation and co-immunoprecipitation assays) or other proteins (for pulldowns assays) immobilized to a solid support. The gold standard solid phases used for
these assays (especially for small scale) are micron-sized porous agarose[49, 154] or nonporous magnetic beads conjugated to specific affinity tags to immobilize proteins and
antibodies to the surface[154, 155].
A pull-down assay confirms or discovers specific protein-protein interactions by
selective extraction using biomolecular recognition and requires a solid support that can
be easily modified for specific functionality. The solid support is usually modified with a
protein, known as the (“bait”), which is known to interact and bind specifically with high
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affinity to the target protein (“prey”) in a complex mixture (eg. lysate). “Bait” proteins
are immobilized to a modified solid support via an affinity tag. Fusion of a glutathione-Stransferase (GST) or multiple histidines are standard “bait” protein affinity tags used for
many protein pull downs[49, 156, 157].
Beads have advantages of high binding capacity due to either increased surface area
of their porous structure such as the case for agarose beads, or an effectively small
surface to volume as is the case for non-porous magnetic beads. Another advantage is the
ease of use for small scale, high throughput, and parallel measurement. However, binding
can be limited by diffusional mass transfer, which can require long equilibration times for
dilute proteins especially in viscous solutions such as lysate. Protein pull-downs could be
performed more rapidly with higher capture efficiency using conditions that promote
mass transfer, such as microfluidics for higher binding efficiency and recovery.
The C-CP fiber packed micro spin column do not compare to the surface area of
porous bead packed columns, but Marcus and coworkers have found that the nonporous
nature of the fibers allow for more convective mass transfer (C-term) of proteins,
meaning potentially more surface area exposed in a dynamic situation, promoting rapid
mass transfer and higher binding efficiency compared to beads for pull-down assays for
dilute proteins in lysate.
For our work, wound PP C-CP fibers packed into 0.8 mm FEP tubing. The resulting
“fiber bundle” was then adapted to be used as a mini-spin column by cutting into 0.5 cm
pieces of the 30 cm “fiber bundle” and fitted onto the end of a micropipette tip. In this
case, the pipet tip served as a reservoir for fluids to be passed through the fiber during
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centrifugation. The fluidic fiber format has other advantages. For example, the polymer
nature of C-CP fibers allows them to be stable at many different pHs and inert to most
aqueous solvents. The resulting microfluidic assay platform is inexpensive, easily
constructed, and easy to use since most of the equipment is commonly found in most
labs, such as a centrifuge, micropipette tips, and centrifuge tubes. Not too mention,
several assays can be performed in parallel. The numbers of assays are just limited by the
number of slots available in the centrifuge rotor.
The study here demonstrates a protein pull-down assay using PP C-CP fiber spin
columns. Proteins bound on the platform will be either be eluted off the solid phases and
analyzed by SDS-PAGE or probed by fluorescent labeled proteins for on-fiber detection.
As a proof of principle assay, we demonstrated platform performance using the anthrax
toxin receptor protein capillary morphogenesis protein 2 (CMG2) as the “bait” and
anthrax protective antigen (PA) as the “prey” protein. In vivo, PA binds to CMG2 and
mediates entry of anthrax toxin into the cell[158,

159]

. Pull-down performance was

compared to that obtained in a similar assay using streptavidin coated magnetic beads.
We hypothesized that the fibers will outperform the beads in cell lysate, due to the mass
transfer advantages of fluidic flow in the fiber channels.
Experimental Section
Materials and Methods
NAv was purchased from Thermo Scientific and hydrated with doubly deionized
water (ddH2O) into a stock of 2 mg/ml. NAv was then diluted into PBS (Cellgro) for
experiments. HEPES buffer saline (HBS) was used to dilute biotinylated-CMG2 and PA.
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HBS was prepared by dissolving NaCl (150 mM), HEPES (50 mM), MgCl2 (1 mM) in
ddH2O, and the adjusting the pH up to 7.9 with 10 M NaOH. A 1% BSA (Fraction V,
OmniPur) stock solution was made by dissolving BSA into PBS. The final blocking
solution was further diluting BSA into PBS to .1% along with Tween-20 (Rockland) for a
total of .1% BSA (w/v) and .01% Tween-20 (v/v) in the blocking solution. NAv-DyLight
(Pierce) was hydrated into a 1 mg/ml stock with ddH2O. Hydrophilic streptavidin
magnetic particles (4 mg/ml) were purchased from New England Biolabs. SDS-PAGE
Express pre-cast gradient gels (4-20%) were purchased from GenScript.
Fiber bundle and spin column construction
The PP C-CP “fiber bundles” were constructed similarly to the method listed above
Protein preparation and labeling
Protein preparation and labeling are explained more in detail elsewhere[160,

161]

.

Maleimide functionalized Alexa Fluor 546 and biotin were added to PA and CMG2C40
respectively as described previously[161].
Functionalizing fibers with NAv-DyLight
The first round of experiments was to show NAv-Dylight binding and compared it to
bare fiber columns with no NAv-Dylight spun through and another set treated first with a
molar equivalent of BSA. Each fiber column was functionalized by serially spinning
through 200 ul PBS, 400 ul NAv-DyLight (.05 mg/ml), and 1 ml PBS. The control group
of bare fiber columns had used 400 ul PBS in place of NAv-Dylight and the other set was
treated with a molar equivalent of BSA followed by treatment with NAv-Dylight.
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A second experiment wanted to determine NAv stability on the fibers in the presence
of blocking solution and its individual components. This was done by visualization and
monitoring fluorescence using NAv-Dylight. Both bare fiber controls and NAv-Dylight
treated fibers were serially treated with the next step of 1 ml of .1% BSA, .1% BSA with
.01% Tween-20, .01% Tween-20, and 1 ml PBS followed by a 1 ml PBS wash. The
fluorescence from the fibers were measured and imaged on-fiber before and after
treatment with blocking solution using the fluorescence microscope. The fluorescence on
the fiber after treatment with blocking solution and its individual components was the
calculated as a ratio of the initial fluorescence of NAv-Dylight before treatment with the
blocking solution.
Biotinylated-EGFP binding experiments
To measure if biotinylated molecules bound to the fiber as well as amount,
biotinylated-EGFP was donated as a generous gift from Dr. George Chumanov to be used
for easily visualization and quantification of biotin bound to fibers and streptavidin
comjugated magnetic beads.
The first experimented was to determine biotinylated-EGFP binding to the NAv
modified fiber tips. For this first NAv was added to the fibers (.05 mg/ml, 400 ul),
followed by 1 ml PBS wash, and the final biotinylated-EGFP solution (50 pmol, 400 ul),
followed by a final 1 ml PBS wash. Two other control groups had buffer used in place of
biotinylated-EGFP and the NAv modification step. The EGFP fluorescence was then
visualized on the fibers using a fluorescence microscope.
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The second experiment used biotinylated-EGFP to measure the amount of biotin
binding (pmol) to fibers and streptavidin magnetic beads by measuring and comparing
the fluorescence of the unbound biotinylated-EGFP in the fiber flow through and post
incubated bead solution to an initial EGFP fluorescence value that was added to both
fibers and beads. The fluorescence was measured using a plate reader (Tecan
instruments).

The values left over were then taken as a percentage of the initial

fluorescence and calculated to its corresponding pmol value based off of 100% unbound
EGFP fluorescence being 50 pmol of biotinylated-EGFP. The values obtained from this
experiment were used later on to adjust and normalize the amount of streptavidin
magnetic beads to biotin binding.
Data acquisition for fluorescence detection
Fluorescence from the fiber columns was imaged with fibers still packed into the FEP
tubing at 2X magnification, using a fluorescence microscope (Olympus). The excitation
and emission filters were set to 575 ex /624 em for Dylight and Alexa Fluor 546
fluorescence detection. Filters were set to 494 ex/531 em for EGFP on fiber fluorescence
measurements.
Probing CMG2 with PA-AlexaFluor 546
All fibers (in triplicate) were treated with 200 ul PBS, 400 ul NAv (.05 mg/ml), 1 ml
blocking solution, 1 ml PBS, 400 ul biotin-CMG2 (50 pmol) (Buffer for negative
control), 1 ml HBS, 400 ul PA-AF546 (various concentration) and 1 ml HBS. The fibers
were then imaged using the fluorescence microscope.
Fiber and bead comparison of PA pull down from lysate
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Four fiber bundles (.5 cm) were assembled into the tip/spin column apparatus where
one of the four was a control with no biotin-CMG2. Each bundle was to receive
periplasmic lysate but at different volumes (100 ul, 1 ml, and 10 ml). All fiber bundles
were functionalized with 200 ul PBS, 400 ul NAv (.05 mg/ml), 1 ml blocking solution, 1
ml PBS, 400 ul biotin-CMG2 (HBS for control), 1 ml HBS, lysate (various volumes), and
1 ml HBS. The control fiber bundle received 1 ml of periplasmic lysate. Four eppendorf
tubes each contained 60 ug of hydrophilic streptavidin coated magnetic beads. The
amount of beads was normalized to bind the same amount of biotin as the fibers
(experimentally determined to be 11 pmol). First, the beads were washed separately in
their respective tubes with 200 ul PBS (incubated 1 min. X 3). The functionalization
method was similar to the fibers where each tube of beads was to receive the lysate at
different volumes with one of the four as a control with no biotin-CMG2. All 4 tubes of
beads were functionalized with the same volumes and reagents as fibers minus the NAv
since they were already functionalized with streptavidin. All incubations for volumes less
than 1 ml were 1 min and 2 min for 1 ml except 20 min incubation for the 10 ml lysate
step. Both fibers and beads had the proteins eluted off with 30 ul of 5% SDS (in PBS).
The 30 ul elutions were analyzed by SDS-PAGE and loaded onto a gel along with a 1 ug
PA standard and molecular weight ladder.
SDS-PAGE gel
A GenScript Express 10 well pre-cast gradient gel (4-20%) was used for analysis. The
1X running buffer was made by dissolving Tris base (6.06 g), MOPS (10.46 g), SDS (1.0
g), and disodium EDTA (.30 g) diluted up to 1000 ml with deionized water. The voltage
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was constant at 140 V. The loading buffer was .3125 M Tris-Cl pH 6.8, 10% SDS, 50%
glycerol, with 2-mercaptoethanol. Samples were loaded by adding 30 ul of elution plus
6ul of 5X loading buffer. The samples, including the PA sample were heated at 95˚ C for
5 min before loading.
Results and discussion
Most pull-downs have a “bait” protein tethered to a solid support that is specific to a
particular protein (“prey”). The “bait” protein is either recombinantly fused to another
protein or tagged to a molecule for it to be tethered to the surface of the solid phase. Pulldowns can be performed on either a large scale, which then chromatography columns
packed with microbeads coated with the “bait” protein or just using the beads as
suspensions in tubes for small-scale reactions. Small scale makes it easier for higher
throughput for parallel assays. Beads are available pre-conjugated to either protein A or
G to immobilize the “bait” IgG for immunoprecipitation assays or tethered to a
glutathione protein to immobilize glutathione-S-transferase fused “bait” proteins[154]. This
helps for selective purification and to not to hinder the binding activity of the “bait”
towards specific protein binding partners. To not hinder the “bait” (CMG2) binding
activity towards PA, CMG2 was tagged with a biotin molecule. To tether it on the
surface, NAv was physically adsorbed to the PP fiber surface. Adsorbed NAv on the fiber
surface will then serve to tether any biotinylated recognition moiety, via the tight NAvbiotin interaction. PP fibers have been previously shown to interact with proteins via
strong hydrophobic interactions. They have also been used in reverse phase
chromatography where the only way to remove proteins from the PP surface was by
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increasing the hydrophobicity of the
A

mobile phase. Both these results
1	
  mm

indicate that the proteins physically
adsorb to the PP surface and by way
of

hydrophobic

However,

there

interactions.

are

no

studies

showing NAv adsorption to PP C-CP
fibers. To demonstrate that NAv
adsorbs to the hydrophobic PP fiber
B

surface, experiments were conducted
with

fluorescently

(NAv-Dylight).

labeled

Images

and

NAv
the

fluorescence of the Dylight were
measured directly from each fiber
column still packed into the FEP
Figure 3.1. Determining NAv adsorption
and stability to PP C-CP fibers. A
Representative fiber images of NAv-Dylight,
BSA pretreatment, and bare fiber with
corresponding barplot of fluorescence
intensity (n=3) with standard deviation bars.
B Barplot of on fiber detection of Dylight
fluorescence as a ratio of before and after
treatment.

tubing

using

microscope.

a

fluorescence

Using

NAv-Dylight

showed that BSA has to adsorb to the
fibers because fibers treated with BSA
before

NAv-Dylight

had

a

significantly lower fluorescence than fibers that were treated with just NAv-Dylight with
no BSA pretreatment. Fluorescent images of fibers treated with NAv-Dylight show
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significant fluorescence versus a negative control (NC) of bare (no protein) treated fiber
(Figure 3.1A) indicating that NAv adsorbs to the PP surface and from the fluorescence
from the fiber shows an even coating. NAv stability was tested against the individual and
combined components of the blocking solution (Tween-20 and BSA) compared to a
control of just PBS. Upon the addition of the blocking step NAv-Dylight fluorescence
decreases significantly compared to the fiber image before the addition of the blocking
solution (Figure 3.1B). The control (PBS treated fibers) showed the least change while
Tween-20 decreased Dylight fluorescence the most. This suggests that both BSA and
Tween-20 compete off NAv-Dylight. BSA contains hydrophobic groups, and the Marcus
and coworkers have showed BSA interaction on PP fibers by physical adsorption.
Tween-20 is a non-ionic surfactant with hydrophobic groups and a long hydro-carbon
chain. Both then have the possibility of binding to the PP surface, which is why they were
originally thought to be used as blocking agents. However, they seem to have stronger
interactions with the PP fibers and compete off the NAv. Therefore, different blocking
agents or concentrations of the BSA and Tween-20 need to be used so as not to compete
off the NAv. However it is still uncertain whether they strip off weakly bound
interactions and the stronger bound protein remain at the surface, or if it is stripping off
weakly bound Dylight dye. Protein activity may be reduced by the conformational
changes when adsorbed to a surface. Therefore, as its conformation changes, then its
binding activity can decreases. Since PP is hydrophobic, NAv would probably have to
unfold to expose some of its hydrophobic patches and bind to the surface of PP with
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multiple van der Waals interactions. This could interfere with its binding activity towards
biotin.
To test if NAv was still active and
bound biotin after adsorption, EGFP
was tagged to a biotin molecule to
Table 1. pmol of biotinylated-GFP bound
to fibers and streptavidin magnetic beads
(n=3)

easily visualize the biotin binding and
to normalize the amount of beads
needed to compare to the fibers. The
fluorescence of EGFP was measured
on the fiber tips using a fluorescence

1 mm
Figure 3.2 NAv modified C-CP fibers
binds biotinylated EGFP. Top Table of the
pmol bound to both fibers and beads (n=3).
Bottom Representative fiber images of EGFP
fluorescence. Far left panel was treated with
NAv and biotin-EGFP, middle panel only
NAv, and right panel biotin-EGFP.

microscope.

The

presence

of

fluorescence on the fiber would then
indicate that biotin bound to the
NAv. The data showed (Table 3.1)

that biotin-EGFP bound to the NAv. Bead quantity was chosen with equivalent biotinbinding based on the results of an experiment to determine biotin binding between fiber
columns and beads. Biotin binding was compared between streptavidin conjugated
magnetic beads and NAv modified fiber tips. The amount bound was determined by
measuring fluorescence of biotin-EGFP added to fibers and beads (the fluorescence value
was considered 100%) and measuring the fluorescence from the flow through of the
fibers and the biotin-EGFP after incubation with the magnetic beads which the
fluorescence was taken as a percentage of the initial fluorescence measurement. The
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magnetic beads were added to compare the total surface area of the fibers, and showed
that more biotin-EGFP bound to the magnetic beads than the fiber tips (Figure 3.2).
Fluorescence has its merits in
analytical detection because of its
sensitivity and low

limits

of

detection since the light that is
detected

is

mostly

from

the

emitting molecule. For this case a
model system was designed to
selectively
Figure 3.3. On-fiber detection of CMG2PA
protein
interaction.
Different
concentrations of labeled PA added to CMG2
modified
C-CP
fibers.
Barplot
of
fluorescence from labeled PA bound to
CMG2 with standard deviation bars (n=3).

extract

and

detect

protein-protein interactions by on
fiber fluorescence detection. The
“bait”

protein

(CMG2)

was

biotinylated and tethered to the
NAv modified fiber via biotin-

NAv interaction, and the “prey” PA was tagged with a fluorophore (PA-AF546).
Different concentrations of purified labeled PA were spun through the biotinylatedCMG2 coated fibers, and the

fluorescence was measured on the fibers using a

fluorescence microscope (Figure 3.3). Only fibers treated with all three proteins (NAv,
biotinylated-CMG2, and PA-AF546) fluoresced compared to negative controls,
indicating specific interaction of PA to CMG2 tethered on the fiber surface. This also
verifies previous experiments that NAv and biotinylated-CMG2 would have to be both
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functionalized near the fiber surface because there was minimal fluorescence seen for
fiber columns not treated with either NAv or biotinylated-CMG2. However, most pulldown assays are performed in more complex solutions with other proteins, and nonspecific binding goes up the more concentrated the proteins are in the solution. Pulldowns are typically performed in complex solutions such as lysate, in which small
quantities of target/analyte protein are presented in high concentrations of other proteins.
To demonstrate specific capture of PA by CMG2 in a complex solution, we treated
CMG2-modified fiber spin columns with perriplasmic lysate from PA-expressing cells.
In this case, columns were treated with different volumes of lysate (.1-10 ml), spanning 2
orders of magnitude. Bound proteins were eluted from tips and visualized using SDS
PAGE (Figure 3.4). Comparison of eluted protein with a PA standard (lane 2) shows
that fiber columns capture PA out of lysate. There was much more non-specific binding
for the fiber columns treated with 10 ml of lysate. Single NAv subunits were also
visualized on the gel for the fiber columns since they matched near 17 kDa on the
molecular weight ladder. There was also faint bands seen near 26 kDa for the fiber
columns treated with biotinylated-CMG2, but not seen for the control fiber (not treated
with biotinylated-CMG2). Also there was not much non-specific binding for volumes
added under 10 ml, and minimal PA non specific binding to both fiber column and beads
that were not treated with biotinylated-CMG2.
For comparison, similar experiments were carried out using streptavidin-modified
magnetic beads. The beads were incubated with lysate for time equivalent to the fiber
spin time. As shown in Figure 3.4, quantities of PA pulled down out of lysate, onto the
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beads, are roughly similar for fiber tips and CMG2-modified beads. There was also much
less non-specific binding for the beads
incubated with the 10 ml of lysate.

Fibers	
   Beads

Conclusion
kDa
95

It was originally hypothesized that

1 2 3 4 5 6 7 8 9 10

the mass transfer properties of fluidic
PA

flow in the fiber channels would perform

Volume: .1-10 ml

better with more efficient extraction than
26

diffusion limited assays such as beads

17

based on previous fiber data indicating
increased mass transport of proteins for
chromatographic separations. However,

Figure 3.4. SDS polyacrylamide gel of
protein(s) eluted from CMG2-modified
fiber bundles and beads.
Fiber tips
modified with NAv and biotin-CMG2 were
treated with lysate from PA-expressing
cells (0.1 mL (lane 3); 1 mL (lane 4); 10
mL (lane 5). Lanes 7 – 10 reflect
corresponding data for NAv-magnetic
beads modified with CMG2-biotin. Fibers
and beads were normalized for biotin
binding to allow comparison of PA capture
by equivalent CMG2 concentration in two
different formats. Total bound protein was
eluted with 5% SDS. The red box (lane 2)
indicates 1 ug of PA standard; lanes 6 and
10 reflect eluate from fibers and beads not
treated with lysate. Protein ladder in far left
lane was used to verify proteins by
molecular weight.

33

in the end, recovery from both fibers and
streptavidin magnetic beads were similar
as shown from the band intensities in the
gel. It is not fully understood as to why
that is. This could be due to mass
transfer limitations or some sort of
kinetic effect concerning the orientation
and density of the “bait” CMG2
immobilized onto the fibers. Even
though

affinity

between

the

biomolecular recognition ligand and protein can be high (as for CMG2 and PA), kinetic
effects on the solid phase can make it appear less so. For example, binding has shown to
also be dependent upon the orientation and surface density[162-165] of the immobilized
affinity ligand. The fiber may still have rapid mass transport, but if the “bait” CMG2 was
not at the optimal density and configuration, the fluid flowing through the fiber channels
might not allow enough time for the PA proteins to stay at the surface to form the
necessary bonds. However, depending on the application will also depend on how much
protein is actually needed.
It is believed that once these questions are answered, the fibers will be a good
material for a selective solid support for small scale immunoprecipitation and pull-down
assays. They have already shown to be selective in a variety of complex mixtures, the
polymer material makes them chemically stable and resistant to a variety of solvents and
pH, they do not dry out, can be reusable, and are stable over long term storage, unlike
beads that over time will eventually aggregate.
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CHAPTER FOUR
CONCLUSIONS
The results in this thesis report successful extraction and on-fiber fluorescence
detection of protein (from cell lysate) and nucleic acids (with fmol LOD and multiplex
detection) using a neutravidin modified fiber based fluidic platform made from PP C-CP
fibers. Protein recovery was similar between fibers and streptavidin conjugated magnetic
microspheres.
Widespread use of solid phase extraction is in part due to the development of simple,
inexpensive, low-tech, easy to use solid phase configurations. The C-CP spin micro
column is simple and cost effective enough to find widespread utility in many different
fields for selective solid phase extraction and also find a place in point of care facilities
for molecular diagnostics. Research to date also shows the use of other fibers and threads
for solid phase extraction and molecular diagnostics assays as an ongoing effort to design
simple, compact, fluidic designs from cheap and high abundant materials. The research is
relatively new and there needs to be more done to better understand how fibers and
threads can effectively be used in these applications. However the literature and the work
done using C-CP fibers shows potential for future fiber fluidic sorbent materials and
configurations that could be utilized for solid phase extraction and molecular diagnostics.
Although the C-CP fiber material and spin configuration are practical and cost
effective, there is room for improvement. Based on this work, it is envisioned that nucleic
acid analysis time can be decreased by coupling visual detection instead of fluorescence
as well as selectively extracting nucleic acids directly from cell lysate. Future work for
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selective protein capture and detection by fundamental studies understanding of protein
affinities, orientation, and ligand surface density on the fibers to ensure optimal protein
capture efficiency.
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